Correlation Between YungShin Global and Sinphar Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both YungShin Global and Sinphar Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining YungShin Global and Sinphar Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between YungShin Global Holding and Sinphar Pharmaceutical Co, you can compare the effects of market volatilities on YungShin Global and Sinphar Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in YungShin Global with a short position of Sinphar Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of YungShin Global and Sinphar Pharmaceutical.
Diversification Opportunities for YungShin Global and Sinphar Pharmaceutical
0.29 | Correlation Coefficient |
Modest diversification
The 3 months correlation between YungShin and Sinphar is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding YungShin Global Holding and Sinphar Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sinphar Pharmaceutical and YungShin Global is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on YungShin Global Holding are associated (or correlated) with Sinphar Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sinphar Pharmaceutical has no effect on the direction of YungShin Global i.e., YungShin Global and Sinphar Pharmaceutical go up and down completely randomly.
Pair Corralation between YungShin Global and Sinphar Pharmaceutical
Assuming the 90 days trading horizon YungShin Global Holding is expected to under-perform the Sinphar Pharmaceutical. In addition to that, YungShin Global is 2.67 times more volatile than Sinphar Pharmaceutical Co. It trades about -0.09 of its total potential returns per unit of risk. Sinphar Pharmaceutical Co is currently generating about -0.17 per unit of volatility. If you would invest 3,275 in Sinphar Pharmaceutical Co on August 29, 2024 and sell it today you would lose (150.00) from holding Sinphar Pharmaceutical Co or give up 4.58% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
YungShin Global Holding vs. Sinphar Pharmaceutical Co
Performance |
| Timeline |
| YungShin Global Holding |
| Sinphar Pharmaceutical |
YungShin Global and Sinphar Pharmaceutical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with YungShin Global and Sinphar Pharmaceutical
The main advantage of trading using opposite YungShin Global and Sinphar Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if YungShin Global position performs unexpectedly, Sinphar Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sinphar Pharmaceutical will offset losses from the drop in Sinphar Pharmaceutical's long position.| YungShin Global vs. Sinphar Pharmaceutical Co | YungShin Global vs. Phytohealth Corp | YungShin Global vs. Excelsior Medical Co | YungShin Global vs. Abnova Taiwan Corp |
| Sinphar Pharmaceutical vs. Abnova Taiwan Corp | Sinphar Pharmaceutical vs. YungShin Global Holding | Sinphar Pharmaceutical vs. Phytohealth Corp | Sinphar Pharmaceutical vs. Wellell |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |